Dr. Joseph Ramek, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Stanford University School of Medicine (1978)
- Years since graduation
- 48
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 556
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1978Medical school: Stanford University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NY license 236468 -
Specialist
NY license 205716-1
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- North Shore University Hospital Manhasset, NY
- Long Island Jewish Medical Center New Hyde PArk, NY
Medical groups
- Optum Medical Care PC (1,010 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 556
- Services billed
- 116,904
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 40,800 | 35 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,100 | 32 |
| Insertion of needle into vein for collection of blood sample | 2,219 | 602 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,900 | 16 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,792 | 547 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,495 | 431 |
| Injection, palonosetron hcl, 25 mcg | 1,371 | 13 |
| Blood test, comprehensive group of blood chemicals | 885 | 369 |
| Injection, dexamethasone sodium phosphate, 1 mg | 642 | 14 |
| Established patient office or other outpatient visit, 40-54 minutes | 491 | 94 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in New Hyde PArk, NY | 60 |
| Brukinsa (zanubrutinib) | 47 |
| Oxycodone Hcl Other prescribers in New Hyde PArk, NY | 34 |
| Lenalidomide | 31 |
| Xarelto (rivaroxaban) Other prescribers in New Hyde PArk, NY | 26 |
| Zolpidem Tartrate Other prescribers in New Hyde PArk, NY | 24 |
| Hydroxyurea Other prescribers in New Hyde PArk, NY | 24 |
| Acyclovir Other prescribers in New Hyde PArk, NY | 23 |
| Anastrozole Other prescribers in New Hyde PArk, NY | 23 |
| Dexamethasone Other prescribers in New Hyde PArk, NY | 23 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 31 payments worth $1,049 in total to this clinician.
| Karyopharm Therapeutics Inc. | $271 |
|---|---|
| Janssen Biotech, Inc. | $200 |
| Novartis Pharmaceuticals Corporation | $113 |
| Incyte Corporation | $99.99 |
| E.r. Squibb & Sons, L.l.c. | $73.60 |
| Alexion Pharmaceuticals, Inc. | $49.42 |
| Beone Medicines USA, Inc. | $47.87 |
| Myriad Genetic Laboratories, Inc. | $43.12 |
| Food and Beverage | $690 |
|---|---|
| Honoraria | $259 |
| Education | $99.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Karyopharm Therapeutics Inc. Nov 5, 2025 | Honoraria XPOVIO · Oncology | $259 |
| Incyte Corporation May 7, 2025 | Education | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.